Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (261-270 of 393) with videos related to

Pageof 40
Sort By:
Plos One|April 14, 2018
Prevalent hepatitis B surface antigen among first-time blood donors in GabonJean Marie Eko Mba, Cyrille Bisseye, Jophrette Mireille Ntsame Ndong, et al.
Hepatology (Baltimore, Md.)|October 12, 2012
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer riskRoongruedee Chaiteerakij, Ju Dong Yang, William S Harmsen, et al.
Gut|September 6, 2024
Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Primrose Tothanarungroj, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 7, 2020
BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort studyNicha Wongjarupong, Gabriela M Negron-Ocasio, Kristin C Mara, et al.
Oncotarget|March 10, 2016
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cellsXiwei Ding, Roongruedee Chaiteerakij, Catherine D Moser, et al.
Transplantation Direct|December 16, 2020
Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis CChung Sang Tse, Ju Dong Yang, Omar Y Mousa, et al.
Hepatology (Baltimore, Md.)|December 27, 2017
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinomaChirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 21, 2015
DNAJB1-PRKACA is specific for fibrolamellar carcinomaRondell P Graham, Long Jin, Darlene L Knutson, et al.
Expert Review of Gastroenterology & Hepatology|June 4, 2020
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective studyMohamed A Abdallah, Nicha Wongjarupong, Mohamed A Hassan, et al.
Hepatology Communications|July 21, 2025
The incidence and predictors of false-negative pancreatobiliary fluorescence in situ hybridization (PB-FISH) in biliary strictures: A prospective studyManik Aggarwal, Gregory J Gores, Eric J Vargas, et al.
Pageof 40

Showing results (261-270 of 393) with videos related to

Sort By:
Pageof 40
Plos One|April 14, 2018
Prevalent hepatitis B surface antigen among first-time blood donors in GabonJean Marie Eko Mba, Cyrille Bisseye, Jophrette Mireille Ntsame Ndong, et al.
Hepatology (Baltimore, Md.)|October 12, 2012
Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer riskRoongruedee Chaiteerakij, Ju Dong Yang, William S Harmsen, et al.
Gut|September 6, 2024
Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021Pojsakorn Danpanichkul, Kanokphong Suparan, Primrose Tothanarungroj, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 7, 2020
BALAD and BALAD-2 predict survival of hepatocellular carcinoma patients: a North American cohort studyNicha Wongjarupong, Gabriela M Negron-Ocasio, Kristin C Mara, et al.
Oncotarget|March 10, 2016
Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cellsXiwei Ding, Roongruedee Chaiteerakij, Catherine D Moser, et al.
Transplantation Direct|December 16, 2020
Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis CChung Sang Tse, Ju Dong Yang, Omar Y Mousa, et al.
Hepatology (Baltimore, Md.)|December 27, 2017
Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinomaChirag Nepal, Colm J O'Rourke, Douglas V N P Oliveira, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 21, 2015
DNAJB1-PRKACA is specific for fibrolamellar carcinomaRondell P Graham, Long Jin, Darlene L Knutson, et al.
Expert Review of Gastroenterology & Hepatology|June 4, 2020
The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective studyMohamed A Abdallah, Nicha Wongjarupong, Mohamed A Hassan, et al.
Hepatology Communications|July 21, 2025
The incidence and predictors of false-negative pancreatobiliary fluorescence in situ hybridization (PB-FISH) in biliary strictures: A prospective studyManik Aggarwal, Gregory J Gores, Eric J Vargas, et al.
Pageof 40